From the Blogs: The Curious Case of M184V, Part 1

May 24, 2017

From the Blogs: The Curious Case of M184V, Part 1

In HIV and ID Observations, Dr. Paul Sax asks about the best antiretroviral regimen for someone with a solo M184V.

A colleague asks Dr. Sax about his go-to regimen in the setting of a solo M184V (methionine replacing valine at position 184 in reverse transcriptase). What would you choose as his antiretroviral regimen? Read the latest HIV and ID Observations blog post and add your voice.

Want to see more from NEJM Journal Watch? Register here.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.